N-able
NABL
4.63
+0.13
+2.89%
N-able
US · NABL
#3371 by market cap
4.63
+0.13
+2.89%
Live - 5344 symbols - heartbeat 96s ago
· 2026-10-09 19:54
✦ Quant Financial Health how this is computed
Weak
- Altman Z-Score is 1.38, below the 1.8 "distress zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +9.30% YoY
Margins
- Gross margin
- 77.11%
- Operating margin
- 7.19%
- Net margin
- -3.33%
Key ratios & quality
- Enterprise valuei
- 1.16B
- Altman Z-Scorei
- 1.38
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 228.29M | 263.52M | 302.87M | 346.46M | 371.77M | 422.16M | 465.55M | 508.84M |
| Gross profit | 170.95M | 206.20M | 239.70M | 294.02M | 313.16M | 353.89M | 384.68M | 391.48M |
| Selling & admin expenses | 95.56M | 109.23M | 139.37M | 193.25M | 196.43M | 204.75M | 211.80M | 254.88M |
| Research & development | 32.89M | 37.17M | 42.72M | 53.96M | 63.48M | 78.18M | 90.71M | 100.71M |
| Operating profit | 18.77M | 36.61M | 33.77M | 33.33M | 47.40M | 70.37M | 81.88M | 33.90M |
| Pretax profit | -17.49M | 3.19M | 4.86M | 11.59M | 30.43M | 44.73M | 54.08M | -167.00K |
| Tax | -3.80M | 5.71M | 12.01M | 11.48M | 13.72M | 20.91M | 23.34M | 18.65M |
| Net profit | -13.69M | -2.51M | -7.16M | 113.00K | 16.71M | 23.82M | 30.74M | -18.82M |
| Basic EPS | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Diluted EPS | -0.04 | -0.01 | -0.02 | 0.00 | 0.09 | 0.13 | 0.16 | -0.10 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 118.20M | 130.52M | 131.71M | 127.68M | 133.68M | 138.22M |
| Gross profit | 90.52M | 101.75M | 102.06M | 96.35M | 101.92M | 106.20M |
| Selling & admin expenses | 64.31M | 65.59M | 64.78M | 60.20M | 62.83M | 62.60M |
| Research & development | 23.88M | 26.34M | 25.19M | 25.31M | 26.14M | 26.63M |
| Operating profit | 1.82M | 9.32M | 11.60M | 10.35M | 12.46M | 16.48M |
| Pretax profit | -3.86M | 415.00K | 7.76M | -5.25M | 4.19M | 7.72M |
| Tax | 3.30M | 5.05M | 6.38M | 3.77M | 4.80M | 5.96M |
| Net profit | -7.16M | -4.63M | 1.38M | -9.01M | -615.00K | 1.76M |
| Basic EPS | 0 | 0 | 0 | 0 | 0 | 0 |
| Diluted EPS | -0.04 | -0.02 | 0.01 | -0.04 | 0.00 | 0.01 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | -- | 71.37M | 135.72M | 120.99M | 154.16M | 224.79M | 183.74M | 216.07M |
| Cash & ST investments | -- | 39.35M | 99.79M | 66.74M | 98.85M | 153.05M | 85.20M | 111.84M |
| Inventory | -- | -- | -- | -- | -- | -- | -- | -- |
| Total assets | -- | 1.01B | 1.08B | 1.06B | 1.08B | 1.16B | 1.34B | 1.41B |
| Total current liabilities | -- | 32.79M | 54.83M | 60.88M | 61.81M | 81.72M | 150.05M | 184.24M |
| Short-term debt | -- | 2.11M | 2.86M | 8.33M | 9.27M | 9.94M | 9.52M | 11.20M |
| Long-term debt | -- | 394.40M | 372.65M | 335.38M | 333.49M | 331.51M | 329.61M | 389.87M |
| Total liabilities | -- | 450,087,000.00 | 448,538,000.00 | 437,344,000.00 | 436,786,000.00 | 451,431,000.00 | 579,507,000.00 | 607,674,000.00 |
| Total equity | -- | 563.70M | 631.20M | 618.36M | 642.07M | 711.36M | 759.56M | 802.04M |
| Retained earnings | -- | -- | 0 | 127.00K | 16.83M | 40.25M | 71.56M | 52.74M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 183.79M | 186.66M | 200.35M | 216.07M | 210.98M | 211.85M |
| Cash & ST investments | 94.09M | 93.87M | 101.44M | 111.84M | 117.81M | 115.81M |
| Inventory | -- | -- | -- | -- | -- | -- |
| Total assets | 1.35B | 1.39B | 1.40B | 1.41B | 1.40B | 1.40B |
| Total current liabilities | 153.67M | 151.09M | 158.36M | 184.24M | 167.40M | 162.36M |
| Short-term debt | 10.17M | 10.41M | 10.50M | 11.20M | 10.36M | 11.33M |
| Long-term debt | 329.12M | 328.64M | 328.16M | 389.87M | 389.10M | 388.33M |
| Total liabilities | 576,976,000.00 | 576,585,000.00 | 584,666,000.00 | 607,674,000.00 | 596,485,000.00 | 590,901,000.00 |
| Total equity | 775.10M | 809.42M | 813.39M | 802.04M | 798.83M | 804.63M |
| Retained earnings | 64.04M | 60.02M | 61.40M | 52.74M | 53.56M | 52.82M |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 52.33M | 25.54M | 85.67M | 45.34M | 71.41M | 90.09M | 79.44M | 93.20M |
| Depreciation & amortization | 56.02M | 54.14M | 56.45M | 33.77M | 24.44M | 21.69M | 25.92M | 44.36M |
| Free cash flow | 42.40M | 17.33M | 69.53M | 10.51M | 50.40M | 67.75M | 55.71M | 63.95M |
| Dividends paid | -- | 0 | 0 | -216.00M | -- | -- | -- | -- |
| Stock buybacks / issuance | -- | 0 | 0 | 216.00M | -- | 0 | 0 | -30.04M |
| Ending cash balance | 77.87M | 39.35M | 99.79M | 66.74M | 98.85M | 153.05M | 85.20M | 111.84M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 19.68M | 24.19M | 24.00M | 25.34M | 17.47M | 26.51M |
| Depreciation & amortization | 10.42M | 10.99M | 10.95M | 12.00M | 11.36M | 10.66M |
| Free cash flow | 13.60M | 17.39M | 14.58M | 18.38M | 13.23M | 14.01M |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -- | -- | -10.00M | -10.04M | -- | -- |
| Ending cash balance | 94.09M | 93.87M | 101.44M | 111.84M | 117.81M | 115.81M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | -- | -0.45 | -1.20 | 0.02 | 2.65 | 3.46 | 4.21 | -2.18 |
| ROA %i | -- | -0.25 | -0.68 | 0.01 | 1.57 | 2.09 | 2.48 | -1.24 |
| ROIC %i | -- | 2.28 | 1.34 | 1.49 | 3.13 | 4.50 | 4.94 | 0.97 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | 0.91 | 1.83 | 1.59 |
| EBIT margin %i | 7.46 | 14.04 | 10.89 | 9.25 | 13.25 | 17.68 | 18.08 | 7.51 |
| FCF / sales %i | 18.57 | 6.57 | 22.96 | 3.03 | 13.56 | 16.06 | 11.95 | 12.50 |
| Current ratioi | -- | 2.18 | 2.48 | 1.99 | 2.49 | 2.75 | 1.22 | 1.17 |
| Quick ratioi | -- | 2.02 | 2.37 | 1.76 | 2.29 | 2.62 | 1.14 | 1.06 |
| Debt / assetsi | -- | 40.29 | 36.13 | 36.14 | 34.84 | 32.21 | 27.57 | 30.53 |
| LT debt / equityi | -- | 72.08 | 61.36 | 60.35 | 57.10 | 51.25 | 47.35 | 52.26 |
| Interest coveragei | 0.49 | 1.09 | 1.17 | 1.57 | 2.61 | 2.47 | 2.81 | 1.07 |
| Revenue CAGR (3Y) %i | -- | -- | -- | 14.92 | 12.16 | 11.71 | 10.35 | 11.03 |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- | 547.95 | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -37.19 | 42.76 | -0.86 | 74.37 | 8.26 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 2.20 | 0.37 | -0.83 | -2.18 | -1.33 | -0.63 |
| ROA %i | 1.31 | 0.22 | -0.50 | -1.24 | -0.76 | -0.37 |
| ROIC %i | 3.56 | 2.33 | 1.55 | 0.97 | 0.96 | 1.40 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 14.18 | 10.96 | 8.66 | 7.51 | 8.91 | 9.96 |
| FCF / sales %i | 14.93 | 13.58 | 12.74 | 12.50 | 12.07 | 11.29 |
| Current ratioi | 1.20 | 1.24 | 1.27 | 1.17 | 1.26 | 1.30 |
| Quick ratioi | 1.07 | 1.12 | 1.14 | 1.06 | 1.12 | 1.16 |
| Debt / assetsi | 27.37 | 26.79 | 26.40 | 30.53 | 31.22 | 31.28 |
| LT debt / equityi | 46.43 | 44.59 | 44.08 | 52.26 | 53.24 | 52.84 |
| Interest coveragei | 2.26 | 1.76 | 1.39 | 1.07 | 1.29 | 1.45 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
Revenue breakdown most recent period
Business
Single segment100.00%
Quote time 2026-10-09 19:54:56 · For reference only, not investment advice and not tailored to your situation.
N-able discussion 0 comments